Skip to main content
SpringerLink
Log in

Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Intravenous immunoglobulin (IVIG) has the potential to regulate Ig production, but the mechanism(s) responsible for this effect is unknown. In experiments reported here, we examined the ability of IVIG to regulate Ig production in human peripheral blood mononuclear cells (PBMCs) stimulated with pokeweed mitogen (PWM). IVIG (2–10 mg/ml) showed a potent (80–85%) inhibition of PWM-stimulated IgG, IgM, and IgA production. To determine more precisely how IVIG mediated the inhibition of Ig production, we studied Ig promoting cytokine gene expression after PWM stimulation with or without IVIG (2 and 10 mg/ml) using dot-blot techniques. RNA was isolated from PBMCs at predetermined time points and probed with cDNAs specific for human cytokines (IL-1-β, IL-2, IL-2R, IL-4, IL-5, IL-6, γ-IFN, and TNF-α). IL-6 mRNA accumulation was maximal at 4.5 hr post-PWM stimulation and was inhibited 64–75% when IVIG (10 mg/ml) was present. γ-IFN mRNA levels peaked at 72 hr poststimulation and were also 68–75% inhibited by IVIG. IL-2 mRNA levels peaked at 4.5 hr and were 23–46% inhibited by IVIG. The inhibitory effect of IVIG on production of these cytokines (IL-6 and γ-IFN) was also observed at the protein level in sonicated PBMCs after incubation with PWM and IVIG. The mRNA levels for other cytokines were not or only minimally inhibited by IVIG. Addition of IL-6, γ-IFN, or IL-2 partially restored Ig production in IVIG-treated PWM-stimulated cultures, suggesting that inhibition of other cytokines or another mechanism(s) independent of cytokine inhibition might also be involved, although inhibition of IL-6, γ-IFN, and IL-2 may be one of the critical factors in the suppression of Ig production by IVIG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kaveri SV, Dietrich G, Hurez V, Kazatchkine MD: Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 86:192–198, 1991

    PubMed  Google Scholar 

  2. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Mori C: High-dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055–1057, 1984

    Google Scholar 

  3. Newburger JW, Takahashi M, Burns JC, Beiser AS, Bhung KJ, Duffy DE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Julton DR, Lewis AB, Leung DYM, Bolton T, Rosen FS, Melish ME: The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347, 1986

    PubMed  Google Scholar 

  4. Jayne DRW, Davies MJ, Fox CJV, Black CM, Lockwood CM: Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 337:1137–1139, 1991

    PubMed  Google Scholar 

  5. Jordan SC: Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 53:S164–169, 1989

    PubMed  Google Scholar 

  6. Sultan Y, Kawatchkine MD, Maisonneuve P, Nydegger UE: Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet II:765–768, 1984

    Google Scholar 

  7. Groothoff JW, Van Leeuwen EF: High dose intravenous gammaglobulin in chonic systemic juvenile arthritis. Br Med J 296:1362–1363, 1988

    Google Scholar 

  8. McGuire WA, Yang HH, Bruno E, Brandt J, Briddell R, Coates TD, Hoffman R: Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. N Engl J Med 317:1004–1008, 1987

    PubMed  Google Scholar 

  9. Lundkvist I, Van Doorn PA, Vermeulen M, Van Lint M, Van Rood JJ, Brand A: Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: Spontaneous and therapeutic. Immunol Rev 110:105–117, 1989

    PubMed  Google Scholar 

  10. Bussel JB, Cunningham-Rundles C, Abraham C: Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox Sang 51:264–269, 1986

    PubMed  Google Scholar 

  11. Hashimoto F, Sakiyama Y, Matsumoto S: The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. Clin Exp Immunol 65:409–415, 1986

    PubMed  Google Scholar 

  12. Stohl W: Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 62:200–207, 1985

    PubMed  Google Scholar 

  13. Durandy A, Fischer A, Griscelli C: Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. J Clin Invest 67:867–877, 1981

    PubMed  Google Scholar 

  14. Ballow M, White W, Desbonnet C: Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin. J Allergy Clin Immunol 84:595–602, 1989

    PubMed  Google Scholar 

  15. Kondo N, Ozawa T, Mushiake K, Motoyoshi F, Kameyama T, Kasahara K, Kaneko H, Yamashina M, Kato Y, Orii T: Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin. J Clin Immunol 11:152–158, 1991

    PubMed  Google Scholar 

  16. O'Garra A, Umland S, De France T, Chistiansen J: B-cell factors are pleiotropic. Immunol Today 9:45–54, 1988

    PubMed  Google Scholar 

  17. Lemire JM, Adams JS, Sakai R, Jordan SC: 1a,25-Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657–661, 1984

    PubMed  Google Scholar 

  18. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA: Nucleotide sequence of human monocyte interleukin 1 precusor cDNA. Proc Natl Acad Sci USA 81:7907–7911, 1984

    PubMed  Google Scholar 

  19. Holbrook NJ, Smith KA, Jornace AJ, Comeau CM, Wiskocil RL, Crabtree GR: T-cell growth factor: Complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc Natl Acad Sci USA 81:1634–1638, 1984

    PubMed  Google Scholar 

  20. Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphey J, Robb RJ, Kronke M, Svetlik PB, Peffer NJ, Waldmann TA, Greene WC: Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631, 1984

    PubMed  Google Scholar 

  21. Yokota T, Otsuka T, Mosmann T, Bancherear J, Defrance T, Blanchard D, De Vries JE, Lee F, Arai K: Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci USA 83:5894–5898, 1986

    PubMed  Google Scholar 

  22. Yokota T, Coffman RL, Hagiwara H, Rennick DM, Takebe Y, Yokota K, Gemmell L, Shader B, Yang G, Meyerson P, Luh J, Hoy P, Pene J, Briere P, Spits H, Banchereau J, De Vries J, Lee JD, Arai N, Arai K: Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: Relationship to interleukin 5. Proc Natl Acad Sci USA 84:7388–7392, 1987

    PubMed  Google Scholar 

  23. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76, 1986

    PubMed  Google Scholar 

  24. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Koh WJ, Aggarwal BB, Goeddel DV: Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724–729, 1984

    PubMed  Google Scholar 

  25. Gray PW, Leung DW, Pennica D, Yelverton E, Najarian R, Simonsen C, Derynck R, Sherwood PJ, Wallace DM, Berger SL, Levinson AD, Goeddel DV: Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503–508, 1982

    PubMed  Google Scholar 

  26. Huck S, Fort P, Crawford DH, Lefranc MP, Lefranc G: Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: Comparison with the other human Cg genes. Nucleic Acid Res 14:1779–1789, 1986

    PubMed  Google Scholar 

  27. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L: Isolation and characterization of full-length cDNA clones for human a-, b-, and g-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 3:787–795, 1983

    PubMed  Google Scholar 

  28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987

    PubMed  Google Scholar 

  29. White BA, Bancroft C: Cytoplasmic dot hybridization. J Biol Chem 257:8569–8572, 1982

    PubMed  Google Scholar 

  30. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201–5205, 1980

    PubMed  Google Scholar 

  31. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995, 1984

    PubMed  Google Scholar 

  32. Feinberg AP, Bogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13, 1984

    Google Scholar 

  33. Feinberg AP, Bogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity: Addendum. Anal Biochem 137, 266–267, 1984

    PubMed  Google Scholar 

  34. Kirk RR:In Experimental Design: Procedures for the Behavioral Sciences, 2nd ed. Belmont, CA, Wadsworth, 1982, pp 106–114

    Google Scholar 

  35. Schiff RI: Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity. Rev Infect Dis 8 (Suppl 4):S449-S456, 1986

    PubMed  Google Scholar 

  36. Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius VA, Wedgwood RJ: The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Med 112:634–640, 1988

    PubMed  Google Scholar 

  37. Moretta L, Webb SR, Grossi CE, Lydyard PM, Cooper MD: Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med 146:184–200, 1977

    PubMed  Google Scholar 

  38. Bich-Thuy LT, Brochier J: Human B cell differentiation. II. Suppression by T cells of T-dependent and T independent plasma cell maturation. J Immunol 122:1842–1848, 1979

    PubMed  Google Scholar 

  39. Kashiwa H, Wright SC, Bonavida B: Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF). J Immunol 138:1383–1390, 1987

    PubMed  Google Scholar 

  40. Bonavida B, Wright S, Kashiwa H, Graves S, Safrit J, Baldwen RL, Wisnieski B, Bramhall J: Immunoregulation and cytotoxicity by tumor necrosis factor.In Tumor Necrosis Factor/Cachectin and Related Cytokines, Bonavida, Gifford, Kirchner, Old (eds). Basel, Karger, 1988, pp 53–58

    Google Scholar 

  41. Stohl W: Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol 136:4407–4413, 1986

    PubMed  Google Scholar 

  42. Keightley RG, Cooper MD, Lawton AR: The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol 117:1538–1544, 1976

    PubMed  Google Scholar 

  43. Rosenberg SA, Lipsky PE: The role of monocytes in pokeweed mitogen-stimulated human B cell activation: Separate requirements for intact monocytes and a soluble monocyte factor. J Immunol 126:1341–1345, 1981

    PubMed  Google Scholar 

  44. Rosenberg SA, Lipsky PE: Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells. J Immunol 122:926–931, 1979

    PubMed  Google Scholar 

  45. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T: The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167:332–344, 1988

    PubMed  Google Scholar 

  46. Leibson HJ, Gefter M, Zlotnik A, Marrack P, Kappler JW: Role of g-interferon in antibody-producing responses. Nature 309:799–801, 1984

    PubMed  Google Scholar 

  47. Sidman CL, Marshall JD, Shults LD, Gray PW, Johnson HM: g-Interferon is one of several direct B cell-maturing lymphokines. Nature 309:801–804, 1984

    PubMed  Google Scholar 

  48. Parker DC: Separable helper factors support B cell proliferation and maturation to Ig secretion. J Immunol 129:469–474, 1982

    PubMed  Google Scholar 

  49. Leibson HJ, Marrack P, Kappler J: B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells. J Immunol 129:1398–1402, 1982

    PubMed  Google Scholar 

  50. Leung DM: Immunomodulation by intravenous immune globulin in Kawasaki disease. J Allergy Clin Immunol 84:588–594, 1989

    PubMed  Google Scholar 

  51. Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Kohi K, Ishikawa H, Ohmoto Y, Yoshizaki K, Hirano T, Kishimoto T: Involvement of IL-6 in mesangial proliferative glomerulonephitis. J Immunol 143:3949–3955, 1989

    PubMed  Google Scholar 

  52. Linker-Israeli M, Deans RJ, Wallace JD, Prehn J, Ozeri-Chen T, Klinenberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123, 1991

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplant Immunology Laboratory, Ahmanson Pediatrics Center, Steven Spielberg Pediatric Research Laboratory, Cedars-Sinai Medical Center/University of California, Los Angeles School of Medicine, 90048, Los Angeles, California

    Mieko Toyoda, Xiaoming Zhang, Anna Petrosian, Odette A. Galera & Stanley C. Jordan

  2. Medical Genetics, Ahmanson Pediatrics Center, Steven Spielberg Pediatric Research Laboratory, Cedars-Sinai Medical Center/University of California, Los Angeles School of Medicine, 90048, Los Angeles, California

    Sue-Jane Wang

Authors
  1. Mieko Toyoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Petrosian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Odette A. Galera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sue-Jane Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stanley C. Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toyoda, M., Zhang, X., Petrosian, A. et al. Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J Clin Immunol 14, 178–189 (1994). https://doi.org/10.1007/BF01533367

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01533367

Key words

Search

Navigation